Related Experiment Videos
Grade and histochemical R-1881 binding in prostatic cancer
Urologia Internationalis
|January 1, 1987
Summary
Prostate cancer malignancy, assessed by Gleason grade, correlates with reduced R-1881 binding to androgen proteins. Relapsed prostate cancers showed no R-1881 binding, regardless of grade.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate cancer progression is linked to androgen receptor (AR) signaling.
- Androphilic proteins, like those binding R-1881, are crucial for AR function.
- Gleason grading is a standard prognostic tool for prostate cancer.
Purpose of the Study:
- To investigate the relationship between Gleason grade and R-1881 binding in prostate cancer tissues.
- To assess R-1881 binding patterns in untreated and relapsed prostate cancer.
Main Methods:
- Tissue samples from 42 untreated and 13 relapsed prostate cancer patients were analyzed.
- R-1881 binding was quantified and correlated with Gleason grades.
- Staining intensity was examined in primary patterns and tumor cell clusters.
Main Results:
- Increasing Gleason grade correlated with decreased R-1881 binding in untreated prostate cancer.
- This loss of binding was observed in both overall tumor patterns and individual cell clusters.
- No R-1881 binding was detected in any grade of relapsed prostate cancer.
Conclusions:
- R-1881 binding intensity serves as a potential biomarker for prostate cancer malignancy.
- Loss of R-1881 binding indicates advanced disease and may predict treatment resistance.
- Further research into AR signaling in relapsed prostate cancer is warranted.